Concert Pharmaceuticals, Inc. - stock earnings
Stock symbol CNCE is outdated, potentially delisted? Maybe it is available on other exchange?
CNCE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -28.9 million USD | 8000 USD |
| 2022Q2 | -23.5 million USD | 21000 USD |
| 2022Q1 | -37.7 million USD | ? USD |
| 2021Q4 | -36.1 million USD | 32.0 million USD |
| 2021Q3 | -26.7 million USD | 543000 USD |
| 2021Q2 | 5.4 million USD | 17000 USD |
| 2021Q1 | -22.7 million USD | 5000 USD |
| 2020Q4 | -22.4 million USD | 7000 USD |
| 2020Q3 | -18.9 million USD | 1.5 million USD |
| 2020Q2 | -13.0 million USD | 6.4 million USD |
CNCE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -80.1 million USD | 32.6 million USD |
| 2020 | -74.8 million USD | 7.9 million USD |
| 2019 | -78.2 million USD | 1.1 million USD |
| 2018 | -56.0 million USD | 10.5 million USD |
| 2017 | 95.6 million USD | 62000 USD |
CNCE
Price: $8.37
52 week price:
Earnings Per Share: -2.74 USD
P/E Ratio: -4.28
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.2 million
Ebitda: 131.1 millionMarket Capitalization: 403.4 million